Descifrando el TDAH: qué es, algunas de sus causas principales y opciones de tratamiento
DOI:
https://doi.org/10.29057/esat.v13i25.14876Palabras clave:
TDAH, bases neurofisiológicas, tratamiento farmacológico, tratamiento no farmacológico, personalización del tratamientoResumen
El trastorno por déficit de atención con hiperactividad (TDAH) es una condición que se ha reportado con frecuencia en niños, aunque también está presente en adultos. A nivel mediático y de redes sociales se habla mucho del TDAH, pero no es común que se hable sobre sus causas a nivel fisiológico, o los diferentes tratamientos que existen para disminuir sus síntomas. En esta revisión de divulgación reunimos información basada en fuentes científicas, abordando de manera asequible las principales causas de este trastorno, así como sus principales tratamientos farmacológicos y no farmacológicos. Derivado de este análisis, hablamos también de uno de los enfoques más recientes para el abordaje del TDAH, tomando como base la diversidad que hay entre los pacientes con esta condición, y revisando algunos de los esfuerzos que se están realizando actualmente por grupos de investigación con el objetivo de personalizar el tratamiento de los pacientes, buscando que sea el más efectivo en cada caso
Descargas
Información de Publicación
Perfiles de revisores N/D
Declaraciones del autor
Indexado en
- Editor y comité editorial
- perfiles
- Sociedad académica
- N/D
Para obtener más información sobre un dato, haga clic 
PF es mantenido por el Public Knowledge Project
Citas
Aldemir, R., Demirci, E., Bayram, A. K., Canpolat, M., Ozmen, S., Per, H., & Tokmakci, M. (2018). Evaluation of Two Types of Drug Treatment with QEEG in Children with ADHD. Translational Neuroscience, 9, 106-116. https://doi.org/10.1515/tnsci-2018-0017
Arns, M., Conners, C. K., & Kraemer, H. C. (2013). A decade of EEG Theta/Beta Ratio Research in ADHD: a meta-analysis. J Atten Disord, 17(5), 374-383. https://doi.org/1087054712460087
Arns, M., Drinkenburg, W., & Leon Kenemans, J. (2012). The effects of QEEG-informed neurofeedback in ADHD: an open-label pilot study. Applied Psychophysiology and Biofeedback, 37(3), 171-180. https://doi.org/10.1007/s10484-012-9191-4
Arns, M., Vollebregt, M. A., Palmer, D., Spooner, C., Gordon, E., Kohn, M.,…Buitelaar, J. K. (2018). Electroencephalographic biomarkers as predictors of methylphenidate response in attention-deficit/hyperactivity disorder. European Neuropsychopharmacology, 28(8), 881-891. https://doi.org/S0924-977X(18)30148-2
Aylward, G. P. (2005). Neurodevelopmental outcomes of infants born prematurely. Journal of Developmental and Behavioral Pediatrics, 26(6), 427-440. http://www.ncbi.nlm.nih.gov/pubmed/16344661
Barry, M. J., Almotawah, F., Pani, S. C., & Ingle, N. A. (2020). A Comparison of Salivary Mercury Levels in Children with Attention Deficit/Hyperactivity Disorder When Compared to Age-matched Controls: A Case-control Observational Study. Journal of Contemporary Dental Practice, 21(2), 129-132. http://www.ncbi.nlm.nih.gov/pubmed/32381815
Bhang, S. Y., Cho, S. C., Kim, J. W., Hong, Y. C., Shin, M. S., Yoo, H. J.,…Kim, B. N. (2013). Relationship between blood manganese levels and children's attention, cognition, behavior, and academic performance--a nationwide cross-sectional study. Environmental Research, 126, 9-16. https://doi.org/10.1016/j.envres.2013.05.006
Bonath, B., Tegelbeckers, J., Wilke, M., Flechtner, H. H., & Krauel, K. (2018). Regional Gray Matter Volume Differences Between Adolescents With ADHD and Typically Developing Controls: Further Evidence for Anterior Cingulate Involvement. J Atten Disord, 22(7), 627-638. https://doi.org/10.1177/1087054715619682
Bong, S. H., & Kim, J. W. (2021). The Role of Quantitative Electroencephalogram in the Diagnosis and Subgrouping of Attention-Deficit/Hyperactivity Disorder. Soa Chongsonyon Chongsin Uihak, 32(3), 85-92. https://doi.org/10.5765/jkacap.210010
Brown, K. A., Samuel, S., & Patel, D. R. (2018). Pharmacologic management of attention deficit hyperactivity disorder in children and adolescents: a review for practitioners. Transl Pediatr, 7(1), 36-47. https://doi.org/10.21037/tp.2017.08.02
Bussalb, A., Congedo, M., Barthelemy, Q., Ojeda, D., Acquaviva, E., Delorme, R., & Mayaud, L. (2019). Clinical and Experimental Factors Influencing the Efficacy of Neurofeedback in ADHD: A Meta-Analysis. Front Psychiatry, 10, 35. https://doi.org/10.3389/fpsyt.2019.00035
Cerrillo-Urbina, A. J., Garcia-Hermoso, A., Pardo-Guijarro, M. J., Sanchez-Lopez, M., Santos-Gomez, J. L., & Martinez-Vizcaino, V. (2018). The Effects of Long-Acting Stimulant and Nonstimulant Medications in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: A Meta-Analysis of Randomized Controlled Trials. Journal of Child and Adolescent Psychopharmacology, 28(8), 494-507. https://doi.org/10.1089/cap.2017.0151
Chiarenza, G. A., Chabot, R., Isenhart, R., Montaldi, L., Chiarenza, M. P., Torto, M. G., & Prichep, L. S. (2016). The quantified EEG characteristics of responders and non-responders to long-term treatment with atomoxetine in children with attention deficit hyperactivity disorders. International Journal of Psychophysiology, 104, 44-52. https://doi.org/S0167-8760(16)30046-0
Clarke, A. R., Barry, R. J., Karamacoska, D., & Johnstone, S. J. (2019). The EEG Theta/Beta Ratio: A marker of Arousal or Cognitive Processing Capacity? Applied Psychophysiology and Biofeedback, 44(2), 123-129. https://doi.org/10.1007/s10484-018-09428-6
Cortese, S., Ferrin, M., Brandeis, D., Holtmann, M., Aggensteiner, P., Daley, D.,…European, A. G. G. (2016). Neurofeedback for Attention-Deficit/Hyperactivity Disorder: Meta-Analysis of Clinical and Neuropsychological Outcomes From Randomized Controlled Trials. Journal of the American Academy of Child and Adolescent Psychiatry, 55(6), 444-455. https://doi.org/10.1016/j.jaac.2016.03.007
Delgado-Mejia, I. D., Palencia-Avendano, M. L., Mogollon-Rincon, C., & Etchepareborda, M. C. (2014). [Theta/beta ratio (NEBA) in the diagnosis of attention deficit hyperactivity disorder]. Revista de Neurología, 58 Suppl 1, S57-63. https://doi.org/rn2014013
Demontis, D., Walters, R. K., Martin, J., Mattheisen, M., Als, T. D., Agerbo, E.,…Neale, B. M. (2019). Discovery of the first genome-wide significant risk loci for attention deficit/hyperactivity disorder. Nature Genetics, 51(1), 63-75. https://doi.org/10.1038/s41588-018-0269-7
Dobrakowski, P., & Lebecka, G. (2020). Individualized Neurofeedback Training May Help Achieve Long-Term Improvement of Working Memory in Children With ADHD. Clinical EEG and Neuroscience, 51(2), 94-101. https://doi.org/10.1177/1550059419879020
Elsayed, N. A., Yamamoto, K. M., & Froehlich, T. E. (2020). Genetic Influence on Efficacy of Pharmacotherapy for Pediatric Attention-Deficit/Hyperactivity Disorder: Overview and Current Status of Research. CNS Drugs, 34(4), 389-414. https://doi.org/10.1007/s40263-020-00702-y
Enriquez-Geppert, S., Smit, D., Pimenta, M. G., & Arns, M. (2019). Neurofeedback as a Treatment Intervention in ADHD: Current Evidence and Practice. Curr Psychiatry Rep, 21(6), 46. https://doi.org/10.1007/s11920-019-1021-4
Gharami, K., Das, M., & Das, S. (2015). Essential role of docosahexaenoic acid towards development of a smarter brain. Neurochemistry International, 89, 51-62. https://doi.org/10.1016/j.neuint.2015.08.014
Giannopoulou, I., Pagida, M. A., Briana, D. D., & Panayotacopoulou, M. T. (2018). Perinatal hypoxia as a risk factor for psychopathology later in life: the role of dopamine and neurotrophins. Hormones (Athens), 17(1), 25-32. https://doi.org/10.1007/s42000-018-0007-7
Herrera-Morales, W. V., Ramirez-Lugo, L., Cauich-Kumul, R., Murillo-Rodriguez, E., & Nunez-Jaramillo, L. (2022). Personalization of Pharmacological Treatments for ADHD: Why it is Advisable and Possible Options to Achieve it. Current Topics in Medicinal Chemistry, 22(15), 1236-1249. https://doi.org/10.2174/1568026622666220509155413
Herrera-Morales, W. V., Reyes-Lopez, J. V., Tuz-Castellanos, K. N., Ortegon-Abud, D., Ramirez-Lugo, L., Santiago-Rodriguez, E., & Nunez-Jaramillo, L. (2023). Variations in Theta/Beta Ratio and Cognitive Performance in Subpopulations of Subjects with ADHD Symptoms: Towards Neuropsychological Profiling for Patient Subgrouping. J Pers Med, 13(9). https://doi.org/10.3390/jpm13091361
Homberg, J. R., Kyzar, E. J., Nguyen, M., Norton, W. H., Pittman, J., Poudel, M. K.,…Kalueff, A. V. (2016). Understanding autism and other neurodevelopmental disorders through experimental translational neurobehavioral models. Neuroscience and Biobehavioral Reviews, 65, 292-312. https://doi.org/10.1016/j.neubiorev.2016.03.013
Hoogman, M., Muetzel, R., Guimaraes, J. P., Shumskaya, E., Mennes, M., Zwiers, M. P.,…Franke, B. (2019). Brain Imaging of the Cortex in ADHD: A Coordinated Analysis of Large-Scale Clinical and Population-Based Samples. American Journal of Psychiatry, 176(7), 531-542. https://doi.org/10.1176/appi.ajp.2019.18091033
Janssen, T. W. P., Gelade, K., Bink, M., van Mourik, R., Twisk, J. W. R., Maras, A., & Oosterlaan, J. (2020). Long-term effects of theta/beta neurofeedback on EEG power spectra in children with attention deficit hyperactivity disorder. Clinical Neurophysiology, 131(6), 1332-1341. https://doi.org/10.1016/j.clinph.2020.02.020
Ji, Y., Choi, T. Y., Lee, J., Yoon, S., Won, G. H., Jeong, H.,…Kim, J. W. (2022). Characteristics of Attention-Deficit/Hyperactivity Disorder Subtypes in Children Classified Using Quantitative Electroencephalography. Neuropsychiatric Disease and Treatment, 18, 2725-2736. https://doi.org/10.2147/NDT.S386774
Krepel, N., Egtberts, T., Sack, A. T., Heinrich, H., Ryan, M., & Arns, M. (2020). A multicenter effectiveness trial of QEEG-informed neurofeedback in ADHD: Replication and treatment prediction. Neuroimage Clin, 28, 102399. https://doi.org/10.1016/j.nicl.2020.102399
Lambez, B., Harwood-Gross, A., Golumbic, E. Z., & Rassovsky, Y. (2020). Non-pharmacological interventions for cognitive difficulties in ADHD: A systematic review and meta-analysis. Journal of Psychiatric Research, 120, 40-55. https://doi.org/10.1016/j.jpsychires.2019.10.007
Lee, C. S. C., Ma, M. T., Ho, H. Y., Tsang, K. K., Zheng, Y. Y., & Wu, Z. Y. (2017). The Effectiveness of Mindfulness-Based Intervention in Attention on Individuals with ADHD: A Systematic Review. Hong Kong J Occup Ther, 30(1), 33-41. https://doi.org/10.1016/j.hkjot.2017.05.001
Leuchter, A. F., McGough, J. J., Korb, A. S., Hunter, A. M., Glaser, P. E., Deldar, A.,…Cook, I. A. (2014). Neurophysiologic predictors of response to atomoxetine in young adults with attention deficit hyperactivity disorder: a pilot project. Journal of Psychiatric Research, 54, 11-18. https://doi.org/S0022-3956(14)00082-X
Li, Y., Cha, C., Lv, X., Liu, J., He, J., Pang, Q.,…Fan, R. (2020). Association between 10 urinary heavy metal exposure and attention deficit hyperactivity disorder for children. Environmental Science and Pollution Research International, 27(25), 31233-31242. https://doi.org/10.1007/s11356-020-09421-9
Loo, S. K., & Makeig, S. (2012). Clinical utility of EEG in attention-deficit/hyperactivity disorder: a research update. Neurotherapeutics, 9(3), 569-587. https://doi.org/10.1007/s13311-012-0131-z
Martinez-Morga, M., Quesada-Rico, M. P., Bueno, C., & Martinez, S. (2018). [Neurobiological bases of autistic spectrum disorder and attention deficit hyperactivity disorder: neural differentiation and synaptogenesis]. Revista de Neurología, 66(S01), S97-S102. http://www.ncbi.nlm.nih.gov/pubmed/29516460
Mohagheghi, A., Amiri, S., Moghaddasi Bonab, N., Chalabianloo, G., Noorazar, S. G., Tabatabaei, S. M., & Farhang, S. (2017). A Randomized Trial of Comparing the Efficacy of Two Neurofeedback Protocols for Treatment of Clinical and Cognitive Symptoms of ADHD: Theta Suppression/Beta Enhancement and Theta Suppression/Alpha Enhancement. Biomed Res Int, 2017, 3513281. https://doi.org/10.1155/2017/3513281
Muratori, P., Conversano, C., Levantini, V., Masi, G., Milone, A., Villani, S.,…Gemignani, A. (2020). Exploring the Efficacy of a Mindfulness Program for Boys With Attention-Deficit Hyperactivity Disorder and Oppositional Defiant Disorder. J Atten Disord, 1087054720915256. https://doi.org/10.1177/1087054720915256
Neurofeedback Collaborative, G. (2020). Double-Blind Placebo-Controlled Randomized Clinical Trial of Neurofeedback for Attention-Deficit/Hyperactivity Disorder With 13-Month Follow-up. Journal of the American Academy of Child and Adolescent Psychiatry. https://doi.org/10.1016/j.jaac.2020.07.906
Nimmo-Smith, V., Merwood, A., Hank, D., Brandling, J., Greenwood, R., Skinner, L.,…Rai, D. (2020). Non-pharmacological interventions for adult ADHD: a systematic review. Psychological Medicine, 50(4), 529-541. https://doi.org/10.1017/S0033291720000069
Núñez-Jaramillo, L., Herrera-Solis, A., & Herrera-Morales, W. V. (2021). ADHD: Reviewing the Causes and Evaluating Solutions. J Pers Med, 11(3). https://doi.org/10.3390/jpm11030166
Ogrim, G., & Kropotov, J. D. (2019). Predicting Clinical Gains and Side Effects of Stimulant Medication in Pediatric Attention-Deficit/Hyperactivity Disorder by Combining Measures From qEEG and ERPs in a Cued GO/NOGO Task. Clinical EEG and Neuroscience, 50(1), 34-43. https://doi.org/10.1177/1550059418782328
Ornoy, A., Becker, M., Weinstein-Fudim, L., & Ergaz, Z. (2021). Diabetes during Pregnancy: A Maternal Disease Complicating the Course of Pregnancy with Long-Term Deleterious Effects on the Offspring. A Clinical Review. International Journal of Molecular Sciences, 22(6). https://doi.org/10.3390/ijms22062965
Pan, M. R., Huang, F., Zhao, M. J., Wang, Y. F., Wang, Y. F., & Qian, Q. J. (2019). A comparison of efficacy between cognitive behavioral therapy (CBT) and CBT combined with medication in adults with attention-deficit/hyperactivity disorder (ADHD). Psychiatry Research, 279, 23-33. https://doi.org/10.1016/j.psychres.2019.06.040
Patel, J. N., Mueller, M. K., Guffey, W. J., & Stegman, J. (2020). Drug Prescribing and Outcomes After Pharmacogenomic Testing in a Developmental and Behavioral Health Pediatric Clinic. Journal of Developmental and Behavioral Pediatrics, 41(1), 65-70. https://doi.org/10.1097/DBP.0000000000000746
Qiu, M. G., Ye, Z., Li, Q. Y., Liu, G. J., Xie, B., & Wang, J. (2011). Changes of brain structure and function in ADHD children. Brain Topography, 24(3-4), 243-252. https://doi.org/10.1007/s10548-010-0168-4
Ros, T., B, J. B., Lanius, R. A., & Vuilleumier, P. (2014). Tuning pathological brain oscillations with neurofeedback: a systems neuroscience framework. Frontiers in Human Neuroscience, 8, 1008. https://doi.org/10.3389/fnhum.2014.01008
Ros, T., Munneke, M. A., Ruge, D., Gruzelier, J. H., & Rothwell, J. C. (2010). Endogenous control of waking brain rhythms induces neuroplasticity in humans. European Journal of Neuroscience, 31(4), 770-778. https://doi.org/10.1111/j.1460-9568.2010.07100.x
Ros, T., Theberge, J., Frewen, P. A., Kluetsch, R., Densmore, M., Calhoun, V. D., & Lanius, R. A. (2013). Mind over chatter: plastic up-regulation of the fMRI salience network directly after EEG neurofeedback. Neuroimage, 65, 324-335. https://doi.org/10.1016/j.neuroimage.2012.09.046
Santonastaso, O., Zaccari, V., Crescentini, C., Fabbro, F., Capurso, V., Vicari, S., & Menghini, D. (2020). Clinical Application of Mindfulness-Oriented Meditation: A Preliminary Study in Children with ADHD. International Journal of Environmental Research and Public Health, 17(18). https://doi.org/10.3390/ijerph17186916
Schonenberg, M., Wiedemann, E., Schneidt, A., Scheeff, J., Logemann, A., Keune, P. M., & Hautzinger, M. (2017). Neurofeedback, sham neurofeedback, and cognitive-behavioural group therapy in adults with attention-deficit hyperactivity disorder: a triple-blind, randomised, controlled trial. Lancet Psychiatry, 4(9), 673-684. https://doi.org/10.1016/S2215-0366(17)30291-2
Schullehner, J., Thygesen, M., Kristiansen, S. M., Hansen, B., Pedersen, C. B., & Dalsgaard, S. (2020). Exposure to Manganese in Drinking Water during Childhood and Association with Attention-Deficit Hyperactivity Disorder: A Nationwide Cohort Study. Environmental Health Perspectives, 128(9), 97004. https://doi.org/10.1289/EHP6391
Smith, T., Sharp, S., Manzardo, A. M., & Butler, M. G. (2015). Pharmacogenetics informed decision making in adolescent psychiatric treatment: a clinical case report. International Journal of Molecular Sciences, 16(3), 4416-4428. https://doi.org/10.3390/ijms16034416
Spencer, T., Biederman, J., Wilens, T., Harding, M., O'Donnell, D., & Griffin, S. (1996). Pharmacotherapy of attention-deficit hyperactivity disorder across the life cycle. Journal of the American Academy of Child and Adolescent Psychiatry, 35(4), 409-432. https://doi.org/S0890-8567(09)63512-7
Tan-Kam, T., Suthisisang, C., Pavasuthipaisit, C., Limsila, P., Puangpetch, A., & Sukasem, C. (2013). Importance of pharmacogenetics in the treatment of children with attention deficit hyperactive disorder: a case report. Pharmacogenomics and Personalized Medicine, 6, 3-7. https://doi.org/10.2147/PGPM.S36782
Van Doren, J., Arns, M., Heinrich, H., Vollebregt, M. A., Strehl, U., & S, K. L. (2019). Sustained effects of neurofeedback in ADHD: a systematic review and meta-analysis. European Child and Adolescent Psychiatry, 28(3), 293-305. https://doi.org/10.1007/s00787-018-1121-4
Van Doren, J., Heinrich, H., Bezold, M., Reuter, N., Kratz, O., Horndasch, S.,…Studer, P. (2017). Theta/beta neurofeedback in children with ADHD: Feasibility of a short-term setting and plasticity effects. International Journal of Psychophysiology, 112, 80-88. https://doi.org/10.1016/j.ijpsycho.2016.11.004
Descargas
Publicado
Cómo citar
Número
Sección
Licencia
Derechos de autor 2025 Dra. Wendy Verónica Herrera Morales, Dr. Luis Núñez Jaramillo
Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-SinDerivadas 4.0.
